Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Pioglitazone on Insulin Action in Type 2 Diabetes
NCT00179400Phase 4Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Dec 2000
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Pioglitazone with Placebo (2 arms). Primary endpoints: Endogenous Glucose Production up to 6 hours and Glucose Rates of Disappearance up to 6 hours. Started Dec 2000; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00179400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179400.